Analyst Ratings for Horizon Pharma PLC (HZNP)

Updated: 2017-07-26

Analysts covering Horizon Pharma PLC (NASDAQ:HZNP) have given it a consensus rating of Buy. About 30 days ago, HZNP was issued an average rating of Buy.

11 analysts issued ratings on the stock, where 9 gave HZNP a buy rating, 0 issued an overweight rating, 2 gave a hold rating, 0 gave an underweight rating, and 0 gave a sell rating. Today, there are 0 more analysts optimistic about the company future as compared with 90 days ago. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

A number of analysts gave price targets for HZNP. The highest price target was 22, which equates to a potential upside of 66.41 percent. The minimum price target given was 10, implying potential capital losses of -24.36 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. The average change in earnings estimates over the last 90 days is -76.76 percent. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of -66.14 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. Over the past month, 0 analysts increased their quarterly estimates, while 0 analysts made negative revisions. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 0 analysts decreased their estimates.

In the last 52-weeks, HZNP has achieved a high of 23.44 and a low of 9.45. Currently the stock is 39.89 percent higher than its low, and 43.6 percent lower than its 52-week high. HZNP has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The HZNP value stock report compares HZNP to some of its peers using value stock charts. The stock has a market capitalization of $2.19 billion. HZNP is estimated to release their earnings results for the quarter on 0000-00-00, days from today.